Status: Not yet recruiting
Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions
A randomized, single-dose, two-way crossover study to evaluate bioequivalence of two formulations of parecoxib after intravenous bolus of parecoxib in healthy volunteers under fasting conditions
Participants needed: 14
Trial details
Phase: Phase 4Age: 20-45Biological sex: AllType: InterventionalSponsor: Yung Shin Pharm. Ind. Co., Ltd.Updated: Sep 20, 2024Locations: 1
Eligibility criteria
Healthy adult male or female subjects between 20-45 years of age (inclusive) at... [+8]
A clinically significant disorder involving the cardiovascular, respiratory, hep... [+16]